Federal Trade Commission
Recent News About Federal Trade Commission
-
NJ Health Reform Group: PBMs 'have been charged with manipulating the market and inflating the cost of medicines for patients'
As Congress enters its lame-duck session following the election, one urgent issue on the legislative agenda is the need to reform the pharmacy benefit manager (PBM) industry. PBMs, which act as intermediaries in the prescription drug supply chain, are under scrutiny for manipulating the market and driving up the cost of medicines for patients.